NCT06389851Completed
Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD
Evaluation of the Effects of Tomato Consumption on the Parameters of Hepatic Steatosis, Intestinal Function and on Glucose and Lipid Metabolism in Subjects With NAFLD
Source: ClinicalTrials.gov · Last updated 16 Apr 2026
Brief summary (registry, in English)
The study in question is an interventional study with nutritional intervention. the aim of the study is to evaluate whether a diet enriched with tomatoes can have favorable effects on: * specific aspects associated with NAFLD, such as the degree of hepatic steatosis and fibrosis; * circulating levels of molecules correlated with the degree of generalized and hepatic inflammation and the blood concentrations of metabolic and cardiovascular risk factors associated with abdominal obesity; * intestinal barrier; * body composition; * intestinal microbiota; * symptoms of IBS (irritable bowel syndrome) in patients with NAFLD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 17 Apr 2024
- Start date
- 14 May 2024
- Primary completion date
- 20 May 2025
- Lead sponsor
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06389851
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 14 May 2024 to the primary completion date, 20 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Serious medical conditions that may compromise participation in the trial;
Other
- Patients with BMI \> 30;
- Presence of any pathology that could influence the presence of steatosis apart from the pathologies that represent inclusion criteria;
- Pregnancy or breastfeeding;
- People following a special diet.
Who the study is looking for
- Patients with BMI≤30;
- Diagnosis of hepatic steatosis, formulated on the basis of criteria
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS "Saverio de Bellis" Coordinator of this site? Confirm its status | Castellana Grotte | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.